Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
出版年份 2022 全文链接
标题
Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
作者
关键词
-
出版物
Pharmaceuticals
Volume 16, Issue 1, Pages 44
出版商
MDPI AG
发表日期
2022-12-29
DOI
10.3390/ph16010044
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeted Strategy in Lipid-Lowering Therapy
- (2022) Ezgi Dayar et al. Biomedicines
- Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study
- (2022) Jonas Brinck et al. DIABETES CARE
- Effect of Cumulative Exposure to Low-Density Lipoprotein-Cholesterol on Cardiovascular Events in Patients With Familial Hypercholesterolemia
- (2021) Hayato Tada et al. CIRCULATION JOURNAL
- Impact of diabetes on coronary severity and cardiovascular outcomes in patients with heterozygous familial hypercholesterolaemia
- (2021) Ming-Ming Liu et al. European Journal of Preventive Cardiology
- Updated Meta-Analysis of Cardiovascular Outcome Trials Evaluating Cardiovascular Efficacy of Glucagon-Like Peptide-1 Receptor Agonists
- (2021) Dimitrios Patoulias et al. AMERICAN JOURNAL OF CARDIOLOGY
- Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
- (2021) Antonio J. Vallejo-Vaz et al. LANCET
- Hipercolesterolemia familiar en Gran Canaria: mutación con efecto fundador y alta frecuencia de diabetes
- (2021) Rosa M. Sánchez-Hernández et al. Clinica e Investigacion en Arteriosclerosis
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments
- (2021) Christos V. Rizos et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Behavioural cardiovascular risk factors and prevalence of diabetes in subjects with familial hypercholesterolaemia
- (2020) Sofia Perez-Calahorra et al. European Journal of Preventive Cardiology
- Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry
- (2020) Christos V. Rizos et al. Lipids in Health and Disease
- Pathophysiology of atherosclerosis: Association of risk factors and treatment strategies using plant‐based bioactive compounds
- (2020) Hina Sharif et al. JOURNAL OF FOOD BIOCHEMISTRY
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Pathophysiology of Diabetic Dyslipidemia
- (2018) Tsutomu Hirano Journal of Atherosclerosis and Thrombosis
- Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry
- (2018) Michal Vrablik et al. ATHEROSCLEROSIS
- The effects of 3-year statin therapy and the achievement of LDL cholesterol target values in familial hypercholesterolemia patients: An experience from Serbia
- (2018) Katarina Lalić et al. ATHEROSCLEROSIS
- Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
- (2018) Christos V. Rizos et al. ATHEROSCLEROSIS
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. EUROPEAN HEART JOURNAL
- Diabetes is Associated with an Increased Risk of Cardiovascular Disease in Patients with Familial Hypercholesterolemia
- (2018) Martine Paquette et al. Journal of Clinical Lipidology
- Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis
- (2018) Leo E. Akioyamen et al. Journal of Clinical Lipidology
- Clinical and genetic characteristics of familial hypercholesterolemia patients with type 2 diabetes
- (2018) D. Sun et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Familial hypercholesterolemia in a European Mediterranean population—Prevalence and clinical data from 2.5 million primary care patients
- (2017) Alberto Zamora et al. Journal of Clinical Lipidology
- Cardiovascular disease in familial hypercholesterolemia: Validation and refinement of the Montreal-FH-SCORE
- (2017) Martine Paquette et al. Journal of Clinical Lipidology
- Statins and New-Onset Diabetes Mellitus: LDL Receptor May Provide a Key Link
- (2017) Qi Yu et al. Frontiers in Pharmacology
- Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia
- (2017) Elisenda Climent et al. Scientific Reports
- Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration
- (2016) Antonio J. Vallejo-Vaz et al. ATHEROSCLEROSIS SUPPLEMENTS
- Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCLINICAL PERSPECTIVE
- (2016) Emil M. deGoma et al. Circulation-Cardiovascular Genetics
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
- (2016) Alberico L. Catapano et al. EUROPEAN HEART JOURNAL
- Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
- (2016) Robert W. Mahley JOURNAL OF MOLECULAR MEDICINE-JMM
- Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia
- (2016) Leopoldo Perez de Isla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
- (2016) Amit V. Khera et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCLINICAL PERSPECTIVE
- (2016) Emil M. deGoma et al. Circulation-Cardiovascular Genetics
- Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes
- (2016) Jon White et al. JAMA Cardiology
- Using Genetic Variants to Assess the Relationship Between Circulating Lipids and Type 2 Diabetes
- (2015) Tove Fall et al. DIABETES
- Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study
- (2015) Francisco Fuentes et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia
- (2015) Dick C. Chan et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus
- (2015) Joost Besseling et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Apolipoprotein B and non-HDL cholesterol are more powerful predictors for incident type 2 diabetes than fasting glucose or glycated hemoglobin in subjects with normal glucose tolerance: a 3.3-year retrospective longitudinal study
- (2014) You-Cheol Hwang et al. ACTA DIABETOLOGICA
- Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14,000 mutation carriers
- (2014) Joost Besseling et al. ATHEROSCLEROSIS
- Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome
- (2014) Barbara Sjouke et al. EUROPEAN HEART JOURNAL
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
- (2013) B. G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Association of Lipid and Lipoprotein Profiles with Future Development of Type 2 Diabetes in Nondiabetic Korean Subjects: A 4-Year Retrospective, Longitudinal Study
- (2011) Mi Hae Seo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites
- (2009) S. S. Martin et al. DIABETES
- Comparison of Genetic Versus Clinical Diagnosis in Familial Hypercholesterolemia
- (2008) Fernando Civeira et al. AMERICAN JOURNAL OF CARDIOLOGY
- Five-year incidence of cardiovascular disease and its predictors in Greece: the ATTICA study
- (2008) Demosthenes B Panagiotakos et al. VASCULAR MEDICINE
- Rising prevalence of diabetes among Greek adults: Findings from two consecutive surveys in the same target population
- (2007) Aristofanis Gikas et al. DIABETES RESEARCH AND CLINICAL PRACTICE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started